IP Library Granted Patent US 11,195,624
Granted Patent B2
US 11,195,624 · App. 15/952,983 · Granted Dec 7, 2021

Integrated health data capture and analysis system

Inventors: Elizabeth A. Holmes (Palo Alto, CA); Ian Gibbons (Newark, CA); Daniel Young (Palo Alto, CA); Seth G. Michelson (San Jose, CA)
Assignee: Labrador Diagnostics LLC
G16H50/50G16H50/20G16H50/70G16H50/80G16Z99/00Y02A90/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,195,624
App. No.
15/952,983
Granted
Dec 7, 2021
Kind
B2
Abstract

The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.

Claims (38)

1. A field testing device, for use with a backend server, for carrying out a testing protocol, comprising:

a testing apparatus that includes:

a cartridge receptacle configured to receive a cartridge containing a bodily sample on which the testing protocol is to be performed;

a plurality of assay units, each having a capture surface and an analyte; and

a plurality of reagent units, each of the plurality of reagent units being associated with and coupled to a corresponding one of the plurality of assay units, and configured to retain and provide controlled distribution of one or more reagents and/or diluents, and to interact with the corresponding plurality of assay units for performing the testing protocol on the received bodily sample;

a transceiver configured to receive the testing protocol from a physically remote central computing device and to transmit test results to the physically remote central computing device;

a memory that stores the testing protocol received from the physically remote central computing device; and

an operating system configured to:

generate and transmit to the backend server a measurement, assay data, a biomarker measurement, or a physiological parameter measurement based on an assay performed according to the testing protocol;

receive from the backend server an adjusted testing protocol; and

execute the adjusted testing protocol.

2. The field testing device of claim 1 , wherein the transceiver is a wireless transceiver configured to communicate over a wireless communication network.

3. The field testing device of claim 1 , further comprising an on-board power source.

4. The field testing device of claim 1 , further comprising a user interface configured to prompt for and receive manually-entered personal information of a patient,

wherein the transceiver is configured to transmit the manually-entered personal information of the patient to the physically remote central computing device.

5. The field testing device of claim 1 , further comprising a location processor configured to determine a location of the field testing device,

wherein the transceiver is configured to transmit the location to the physically remote central computing device.

6. The field testing device of claim 1 , wherein the testing protocol specifies at least one of the bodily sample to be tested, the analyte to be used, or the one or more reagents and/or diluents to be used.

7. The field testing device of claim 1 , further comprising a tag reader configured to extract information from a tag associated with the testing apparatus.

8. A field testing device, for use with a backend server, for carrying out a testing protocol, comprising:

a testing apparatus that includes:

a device-readable identification tag that stores identification information relating to the testing apparatus;

a cartridge receptacle configured to receive a cartridge containing a bodily sample on which the testing protocol is to be performed;

a plurality of assay units, each having a capture surface and an analyte; and

a plurality of reagent units, each of the plurality of reagent units being associated with and coupled to a corresponding one of the plurality of assay units, and configured to retain and provide controlled distribution of one or more reagents and/or diluents, and to interact with the corresponding plurality of assay units for performing the testing protocol on the received bodily sample;

a tag reader configured to extract the identification information from the device-readable identification tag;

a transceiver configured to transmit the identification information to a physically remote central computing device, receive the testing protocol from the physically remote central central computing device in response to the transmission of the identification information, and transmit test results to the physically remote central computing device;

a memory that stores the testing protocol and the test results; and

an operating system configured to:

generate and transmit to the backend server a measurement, assay data, a biomarker measurement, or a physiological parameter measurement based on an assay performed according to the testing protocol;

receive from the backend server an adjusted testing protocol; and

execute the adjusted testing protocol.

9. The field testing device of claim 8 , wherein the identification information includes at least one of a unique identifier or a type of the testing apparatus.

10. The field testing device of claim 9 , wherein the received adjusted testing protocol includes addresses of the plurality of assay units selected based on the identification information.

11. The field testing device of claim 10 , wherein the transceiver is further configured to receive an updated testing protocol from the physically remote central computing device that includes updated addresses of the plurality of assay units.

12. The field testing device of claim 11 , wherein the updated addresses of the plurality of assay units cause the field testing device to implement an updated test associated with the updated testing protocol.

13. The field testing device of claim 8 , wherein the device-readable identification tag is a barcode, and the tag reader is an optical barcode scanner.

14. The field testing device of claim 8 , wherein the device-readable identification tag is an NFC tag or an RFID tag.

Assignments (1)
CHANGE OF NAME Recorded Apr 7, 2020
From: THERANOS IP COMPANY LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052329/0716 →
Continuity (5)
Continuation 15246401 · Aug 24, 2016
Continuation 14511753 · Oct 10, 2014
Continuation 12906975 · Oct 18, 2010
Provisional Application 61253015 · Oct 19, 2009
Related Publication 20180374582A1 · Dec 27, 2018
Cited By (1)
US 12,288,610